Brazil Regulator Approves Cirugica Mafra Acquisition by Viveo

Brazil antitrust regulator Cade’s superintendence approved the deal without restrictions, according to official gazette and Cade’s website.

• NOTE: Viveo Agrees to Buy Profarma, Mafra; Deals Valued at BRL900m
• NOTE: Decisions made by Cade’s superintendence can be reassessed on court’s floor if board members consider that a deeper analysis of an operation is needed

Original Story:

Cade aprova compra da Cirúrgica Mafra pela Viveo

To contact the translator on this story:
Danielle Chaves in Sao Paulo at djelmayer@bloomberg.net

Reporter on the original story:
Danielle Chaves in Sao Paulo at djelmayer@bloomberg.net

Editor responsible for the original story:
Ney Hayashi at ncruz4@bloomberg.net ...